Eli Lilly Chief Scientific Officer explains Zepbound’s weight loss advantage
Dan Skovronsky, Eli Lilly Chief Scientific Officer, joins ‘Fast Money’ to talk Zepbound’s recent trial results and what it means for Eli Lilly’s future growth.
Share
Dan Skovronsky, Eli Lilly Chief Scientific Officer, joins ‘Fast Money’ to talk Zepbound’s recent trial results and what it means for Eli Lilly’s future growth.
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Homin Lee of Lombard Odier says that based on what Trump has promised on the campaign trail, the outlook for Asian markets is negative, but investors should be patient to see what actually comes to pass before making any tactical allocations in…
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Warren Pies, 3Fourteen Research co-founder, joins ‘Closing Bell’ to discuss the market’s recent uptrend, where Pies is starting to have concerns, and more. Source link
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Fabio Balboni, senior European economist at HSBC, discusses the outlook for interest rate cuts from the European Central Bank and economic growth in Europe. Source link
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email CNBC Markets Now CNBC Markets Now provides a look at the day’s market moves with commentary and analysis from Michael Santoli, CNBC Senior Markets Commentator. 01:06 30 minutes ago Source link
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email JPMorgan’s Gabriela Santos, Virtus’ Joe Terranova and BMO Wealth’s Yung-Yu Ma, join ‘Closing Bell’ to discuss the markets as stocks retreat from record highs and earnings season. 19:13 Thu, Dec 5 20244:18 PM EST Source link
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Shyam Sankar, Palantir chief technology officer, joins CNBC’s ‘Closing Bell Overtime’ to discuss the company’s partnership with Booz Allen and others, the role AI plays in defense, and more. Source link